CARDIFF ONCOLOGY, INC. Paid-in-Kind Interest
CARDIFF ONCOLOGY, INC. (CRDF) reported Paid-in-Kind Interest of $757.20 thousand for the 176-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2014-05-12
- CARDIFF ONCOLOGY, INC. paid-in-kind interest for the quarter ending 2011-12-31 was -$1.00.
- CARDIFF ONCOLOGY, INC. paid-in-kind interest for the quarter ending 2011-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. paid-in-kind interest for the quarter ending 2011-06-30 was $28.13K.
- CARDIFF ONCOLOGY, INC. paid-in-kind interest for the quarter ending 2011-03-31 was $28.51K.
- CARDIFF ONCOLOGY, INC. paid-in-kind interest for fiscal 2011 was $56.64K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month | Paid-in-Kind Interest 152 month | Paid-in-Kind Interest 155 month | Paid-in-Kind Interest 158 month | Paid-in-Kind Interest 161 month | Paid-in-Kind Interest 164 month | Paid-in-Kind Interest 167 month | Paid-in-Kind Interest 170 month | Paid-in-Kind Interest 173 month | Paid-in-Kind Interest 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $757.20K 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $757.20K 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | $757.20K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $757.20K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $757.20K 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | $757.20K 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $757.20K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $757.20K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $757.20K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$1.00 derived: sum of 2 quarters · filed 2014-03-17 | $28.13K derived: sum of 3 quarters · filed 2014-03-17 | $56.64K 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $28.13K derived: sum of 2 quarters · filed 2012-11-14 | $56.64K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | $28.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $56.64K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $28.51K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |